— McKesson Corporation (NYSE: MCK) reported third-quarter 2019 earnings of $3.60 per share, in line with the street projection.
— Total revenue grew 9% to $57.62 billion, vs $55.07 billion expected. The topline was driven by its US Pharmaceutical and Specialty Solutions segment.
— Revenues from US Pharma segment were $46.0 billion, up 10%, driven by branded pharmaceutical price increases and increased specialty pharmaceutical volumes.
— Reaffirms fiscal 2020 adjusted EPS guidance range of $14.00 – $14.60.
— CME shares have gained 0.7% immediately following the announcement.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Omnichannel push, margin dynamics in focus as Walmart gears up for Q3 earnings
Walmart Inc. (NYSE: WMT) entered the second half of FY26 navigating a challenging retail landscape marked by tariff-related cost pressure and cautious consumer behavior. At the same time, the company
AMAT Earnings: Applied Materials Q4 adjusted profit drops on lower revenues
Semiconductor equipment maker Applied Materials, Inc. (NASDAQ: AMAT) on Thursday reported a decrease in adjusted earnings for the fourth quarter of fiscal 2025. Adjusted earnings declined to $2.17 per share
Disney’s (DIS) streaming business continues its momentum in Q4 2025
Shares of The Walt Disney Company (NYSE: DIS) fell 9% on Thursday after the company delivered mixed results for the fourth quarter of 2025. While earnings beat expectations, revenues fell
